USA – Sanofi and Regeneron have added another string to the bow of their immunology blockbuster Dupixent with an FDA approval for treatment of oesophagitis (EoE), which could help the…
Read MoreSanofi’s Dupixent wins US approval for expanded use
Tag: Regeneron
Regeneron beefs up oncotherapy portfolio with US$250M Checkmate Pharma buyout
USA – Regeneron Pharmaceuticals has shelled out US$250 million cash to acquire Checkmate Pharmaceuticals, a clinical-stage biotech developing drugs that activate the innate immune system. Regeneron will pay US$10.50 in…
Read MoreFDA approves Sanofi’s Enjaymo for treatment of rare blood disease
FRANCE – The US FDA has approved Enjaymo (sutimlimab-jome) infusion to reduce the need for red blood cell transfusion due to hemolysis (red blood cell destruction) in adults with cold…
Read MorePfizer backs out of vupanorsen development, hands back rights to partner Ionis
USA – Pfizer has terminated its collaboration with Ionis for the cholesterol-lowering therapy vupanorsen, following a review of phase 2b data that raised concerns about the antisense drug’s efficacy and…
Read MoreRoche looks to compete against Regeneron’s blockbuster with its newly approved vision drug
SWITZERLAND – Roche announced that it has received FDA approval for the first-ever bispecific antibody treatment for two common causes of vision loss, paving the way for a battle with…
Read MoreRoche’s arthritis drug scores EMA approval for treating severe Covid-19
NETHERLANDS – The European Medicines Agency (EMA) has recommended extending the use of Roche’s RoActemra arthritis drug for adult COVID-19 patients receiving systemic steroid treatment and those requiring oxygen support…
Read MoreGSK & Vir Biotech sign pact with U.S to supply Covid-19 antibody therapy doses worth US$1 billion
USA – The US government has signed contracts worth approximately US$1 billion to secure the antibody-based Covid-19 treatment developed by GlaxoSmithKline (GSK) and Vir Biotechnology, the drug makers have announced.…
Read MoreDenmark’s Novo Nordisk reaches US$3.3 billion deal to acquire Dicerna Pharma
DENMARK – Novo Nordisk, a Danish pharmaceutical company, has agreed to buy Dicerna Pharmaceuticals for US$3.3 billion in cash, the company has announced. Dicerna Pharmaceuticals creates RNAi-based therapies that selectively…
Read MoreRoche terminates partnership to develop COVID-19 pill with Atea
SWITZERLAND – Roche Holding AG has terminated its collaboration with Atea Pharmaceuticals Inc.to develop a COVID-19 antiviral pill, the Swiss drugmaker has announced. The partnership termination has happened a month…
Read MorePfizer’s new antiviral pill cuts hospitalization risk, death from Covid-19 by nearly 90%
USA – Pfizer has announced that Paxlovid, an investigational oral antiviral, reduced COVID-19-related hospitalizations and deaths by 89 percent in a phase 2/3 study of nonhospitalized adults at high risk…
Read More